Latest BVF INC/IL Stock Portfolio
$3.14Billion– No. of Holdings #41
BVF INC/IL Performance:
2026 Q1: 5.19%YTD: 5.19%2025: 18.34%
Performance for 2026 Q1 is 5.19%, and YTD is 5.19%, and 2025 is 18.34%.
About BVF INC/IL and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, BVF INC/IL reported an equity portfolio of $3.1 Billions as of 31 Mar, 2026.
The top stock holdings of BVF INC/IL are KYMR, MLTX, RVMD. The fund has invested 14.6% of it's portfolio in KYMERA THERAPEUTICS INC and 9.5% of portfolio in MOONLAKE IMMUNOTHERAPEUTICS.
The fund managers got completely rid off ABIVAX SA, REPARE THERAPEUTICS INC (RPTX) and PEPGEN INC (PEPG) stocks. They significantly reduced their stock positions in 4D MOLECULAR THERAPEUTICS IN (FDMT), SEPTERNA INC and MOONLAKE IMMUNOTHERAPEUTICS (MLTX). BVF INC/IL opened new stock positions in ALKERMES PLC (ALKS), SUTRO BIOPHARMA INC (STRO) and ANTERIS TECHNOLOGIES GLOBAL. The fund showed a lot of confidence in some stocks as they added substantially to DISC MEDICINE INC, NEKTAR THERAPEUTICS (NKTR) and IMAGENEBIO INC (IKNA).
The top stock holdings of BVF INC/IL are KYMR, MLTX, RVMD. The fund has invested 14.6% of it's portfolio in KYMERA THERAPEUTICS INC and 9.5% of portfolio in MOONLAKE IMMUNOTHERAPEUTICS.
The fund managers got completely rid off ABIVAX SA, REPARE THERAPEUTICS INC (RPTX) and PEPGEN INC (PEPG) stocks. They significantly reduced their stock positions in 4D MOLECULAR THERAPEUTICS IN (FDMT), SEPTERNA INC and MOONLAKE IMMUNOTHERAPEUTICS (MLTX). BVF INC/IL opened new stock positions in ALKERMES PLC (ALKS), SUTRO BIOPHARMA INC (STRO) and ANTERIS TECHNOLOGIES GLOBAL. The fund showed a lot of confidence in some stocks as they added substantially to DISC MEDICINE INC, NEKTAR THERAPEUTICS (NKTR) and IMAGENEBIO INC (IKNA).
BVF INC/IL Equity Portfolio Value
Last Reported on: 15 May, 2026
BVF INC/IL Annual Return Estimates Vs S&P 500
Our best estimate is that BVF INC/IL made a return of 5.19% in the last quarter. In trailing 12 months, it's portfolio return was 56.38%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| alkermes plc | 70,720,000 |
| sutro biopharma inc | 31,182,000 |
| anteris technologies global | 16,650,000 |
| onkure therapeutics inc | 8,192,940 |
New stocks bought by BVF INC/IL
Additions
| Ticker | % Inc. |
|---|---|
| disc medicine inc | 95.74 |
| nektar therapeutics | 64.12 |
| imagenebio inc | 38.39 |
| avalo therapeutics inc | 20.48 |
| monte rosa therapeutics inc | 16.29 |
| stoke therapeutics inc | 12.44 |
| foghorn therapeutics inc | 10.18 |
| palvella therapeutics inc ne | 9.33 |
Additions to existing portfolio by BVF INC/IL
Reductions
| Ticker | % Reduced |
|---|---|
| 4d molecular therapeutics in | -37.8 |
| septerna inc | -21.36 |
| moonlake immunotherapeutics | -18.99 |
| revolution medicines inc | -14.9 |
| immunocore hldgs plc | -13.06 |
| tyra biosciences inc | -7.12 |
| zymeworks inc | -5.19 |
| annexon inc | -4.71 |
BVF INC/IL reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| repare therapeutics inc | -26,867,400 |
| pepgen inc | -12,466,600 |
| abivax sa | -68,510,500 |
| axsome therapeutics inc | -8,357,060 |
BVF INC/IL got rid off the above stocks
Sector Distribution
BVF INC/IL has about 73.8% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 73.8 |
| Others | 25.4 |
Market Cap. Distribution
BVF INC/IL has about 8.9% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- UNALLOCATED
- MID-CAP
- LARGE-CAP
- MICRO-CAP
| Category | % |
|---|---|
| SMALL-CAP | 38.2 |
| UNALLOCATED | 25.4 |
| MID-CAP | 21.5 |
| LARGE-CAP | 8.9 |
| MICRO-CAP | 6.1 |
Stocks belong to which Index?
About 59.4% of the stocks held by BVF INC/IL either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 59.4 |
| Others | 40.6 |
BVF INC/IL Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BVF INC/IL
BVF INC/IL has 41 stocks in it's portfolio. About 62.2% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. MLTX was the most profitable stock for BVF INC/IL last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACIU | ac immune sa | 1.74 | 19,822,400 | 54,511,700 | unchanged | 0.00 | ||
| ADGI | invivyd inc | 0.81 | 19,525,000 | 25,382,500 | unchanged | 0.00 | ||
| ALKS | alkermes plc | 2.25 | 2,000,000 | 70,720,000 | new | |||
| ANNX | annexon inc | 1.53 | 8,698,170 | 48,187,900 | reduced | -4.71 | ||
| AVTX | avalo therapeutics inc | 0.78 | 1,632,840 | 24,378,400 | added | 20.48 | ||
| AXSM | axsome therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CGEM | cullinan therapeutics inc | 2.60 | 5,750,680 | 81,717,200 | unchanged | 0.00 | ||
| CMPX | compass therapeutics inc | 1.31 | 7,764,840 | 41,076,000 | unchanged | 0.00 | ||
| ELDN | eledon pharmaceuticals inc | 0.62 | 6,293,280 | 19,383,300 | unchanged | 0.00 | ||
| FDMT | 4d molecular therapeutics in | 0.85 | 2,879,290 | 26,806,200 | reduced | -37.8 | ||
| FHTX | foghorn therapeutics inc | 0.89 | 5,842,000 | 27,924,800 | added | 10.18 | ||
| GHRS | gh research plc | 3.87 | 8,650,160 | 121,621,000 | reduced | -2.01 | ||
| GLUE | monte rosa therapeutics inc | 2.34 | 4,460,890 | 73,381,600 | added | 16.29 | ||
| IKNA | imagenebio inc | 0.18 | 1,110,000 | 5,550,010 | added | 38.39 | ||
| IMCR | immunocore hldgs plc | 1.24 | 1,294,460 | 39,028,100 | reduced | -13.06 | ||
| IMUX | immunic inc | 0.27 | 765,297 | 8,494,800 | unchanged | 0.00 | ||
| IVA | inventiva sa | 0.12 | 686,040 | 3,807,520 | unchanged | 0.00 | ||
| KURA | kura oncology inc | 2.19 | 8,445,770 | 68,664,100 | reduced | -1.99 | ||
| KYMR | kymera therapeutics inc | 14.60 | 5,502,710 | 458,321,000 | unchanged | 0.00 | ||
| MIRM | mirum pharmaceuticals inc | 4.66 | 1,584,730 | 146,397,000 | added | 5.98 | ||